Condition: Resectable Hepatocellular Carcinoma · Sponsor: Fundacion Clinic per a la Recerca Biomédica
Study to evaluate the efficacy and safety of the combination of Atezolizumab and Bevacizumab as neoadjuvant plus adjuvant treatment in Hepatocellular Carcinoma.
This description comes directly from the study's public registry record.
Ezequiel Matias Mauro, MD, PhD · +34 932275400 · mauro@recerca.clinic.cat
Eva Bonfill Vernet · +34 932275400 · bonfill@recerca.clinic.cat
Always discuss trial participation with your own doctor first.
| Hospital Universitari Germans Trias i Pujol | Badalona, Barcelona, Spain | Recruiting |
| Hospital Universitari de Bellvitge | Barcelona, Barcelona, Spain | Recruiting |
| Hospital Universitari Vall d'Hebron | Barcelona, Barcelona, Spain | Recruiting |
| Hospital Universitario Marqués de Valdecilla | Santander, Cantabria, Spain | Recruiting |
| Hospital Universitario Reina Sofía | Córdoba, Cordoba, Spain | Recruiting |
| Hospital Universitari Josep Trueta | Girona, Girona, Spain | Recruiting |
| Hospital General Universitario Gregorio Marañón | Madrid, Madrid, Spain | Recruiting |
| Hospital Universitario Ramón y Cajal | Madrid, Madrid, Spain | Recruiting |
| Hospital Universitario Fundación Jiménez Díaz | Madrid, Madrid, Spain | Recruiting |
| Hospital Universitario Virgen de la Victoria | Puerto de la Torre, Málaga, Spain | Recruiting |
| Hospital Universitario y Politécnico La Fe | Valencia, Valencia, Spain | Recruiting |
| Hospital Universitario de Cruces | Barakaldo, Vizcaya, Spain | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07018947